BRCA1 and central nervous system cancer: In glioma disease, RRM2 can promote human glioblastoma cell proliferation, migration and invasion and RRM2 expression controlled by BRCA1 can protect glioblastoma cells from endogenous replication stress while also increasing tumorigenicity [85, 86].